Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety, tolerability, and preliminary efficacy of an oral psilocybin solution in adults with generalized anxiety disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Psilocybin oral solution (psilocybin)

Snippet

Sponsor: Queen's University | Conditions: Generalized Anxiety Disorder (GAD) | Phase 2 | Status: RECRUITING